Sone Capital Management LLC Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH

Sone Capital Management LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 65,402 shares of the financial services provider’s stock, valued at approximately $10,901,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Brighton Jones LLC increased its position in Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC boosted its holdings in Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares in the last quarter. Glenview Trust co grew its stake in Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after acquiring an additional 379 shares during the period. Osterweis Capital Management Inc. raised its position in shares of Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after purchasing an additional 922 shares during the period. Finally, Diversify Advisory Services LLC bought a new stake in Marsh & McLennan Companies during the 2nd quarter valued at $1,307,000. 87.99% of the stock is owned by institutional investors.

Marsh & McLennan Companies Stock Performance

Marsh & McLennan Companies stock opened at $194.61 on Tuesday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $211.28. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock’s 50-day moving average price is $180.45. The stock has a market capitalization of $92.87 billion, a PE ratio of 23.79, a PEG ratio of 2.75 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion during the quarter. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, analysts predict that Marsh & McLennan Companies, Inc. will post 10.43 EPS for the current fiscal year.

Marsh & McLennan Companies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Thursday, July 23rd were issued a dividend of $0.99 per share. This represents a $3.96 dividend on an annualized basis and a yield of 2.0%. This is an increase from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio is 48.41%.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, SVP Paul Beswick sold 713 shares of the company’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total value of $141,174.00. Following the completion of the transaction, the senior vice president owned 16,376 shares in the company, valued at $3,242,448. This represents a 4.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Martin South sold 7,100 shares of the firm’s stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total value of $1,348,929.00. Following the sale, the insider directly owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. This represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 36,469 shares of company stock worth $6,291,345 in the last ninety days. Company insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on MRSH shares. JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Cantor Fitzgerald raised their price target on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. UBS Group boosted their price objective on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Weiss Ratings upgraded Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, August 7th. Finally, Citigroup cut Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price on the stock. in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $203.50.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.